Yellow pages to the transcriptome
Julia Scheel, Marie‐Charlotte von Brevern, Andreas Hörlein et al. · Pharmacogenomics · 2002
Transcriptomics has become an important tool for the large-scale analysis of biological processes. This review aims to provide sufficient criteria to make an appropriate choice among the variety of 'closed' systems, represented by DNA microarrays, and 'open' systems like fragment display, tag sequencing and subtractive hybridization, depending on the biological system under investigation. The most important technologies currently available are presented, their strengths and weaknesses are discussed and companies active in the field are listed. The potential of transcriptomics in the pharmaceutical research and development process is highlighted by applications in oncology, research on neurological diseases, and predictive toxicology. Finally, a prognosis for future developments of the technologies is given.
Cited by 26 works. doi:10.1517/14622416.3.6.791
Authors
References
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
- Molecular portraits of human breast tumours
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Gene expression profiling predicts clinical outcome of breast cancer
- Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
- Reversible middle cerebral artery occlusion without craniectomy in rats.
- Systematic variation in gene expression patterns in human cancer cell lines
- Molecular classification of cutaneous malignant melanoma by gene expression profiling
- [12] DNA arrays for analysis of gene expression